Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Vomiting 14Nausea 11Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma 3Lymphoma, Non-Hodgkin 2Leukemia 2Breast Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Solid Tumours 1Sezary Syndrome 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Papillomavirus Infections 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1

Interventions

fludarabine phosphate 5Mycophenolic Acid 5Cyclosporine 5Whole-Body Irradiation 4Peripheral Blood Stem Cell Transplantation 4Therapeutics 3midostaurin 2avapritinib 2Psychiatric Rehabilitation 2Early Intervention, Educational 2Darbepoetin alfa 2thymoglobulin 1ripretinib 1liposomal doxorubicin 1hydrocortisone valerate 1ferrous sulfate 1ferric gluconate 1denileukin diftitox 1Sunitinib 1Sucrose 1Rituximab 1Pemetrexed 1Music Therapy 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1Methylprednisolone 1Methotrexate 1Massage 1MK 2206 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Mast-Cell × Granisetron × Clear all
NCT00186628 2017-11-28

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Stanford University

Phase 2 Completed
36 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Mast-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡